Publications by authors named "Brian Platt"

Claim this Profile
C
CXCL12-induced rescue of cortical dendritic spines and cognitive flexibility.
Lindsay K Festa, Elena Irollo, Brian J Platt, Yuzen Tian, Stan Floresco

Elife· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Actuopaleoichnology of a modern Bay of Fundy macro-tidal flat: analogy with a Mississippian tidal flat deposit (Hartselle Sandstone) from Alabama.
Louis G Zachos, Brian F Platt

PeerJ· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LIDAR-based characterization and conservation of the first theropod dinosaur trackways from Arkansas, USA.
Brian F Platt, Celina A Suarez, Stephen K Boss, Malcolm Williamson, Jackson Cothren

PLoS One· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling an Inflammation-Related Depressive Phenotype in Mice Using Bacille Calmette-Guérin.
Brian J Platt, Janet A Clark

Curr Protoc Neurosci· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A depressive phenotype induced by Bacille Calmette Guérin in 'susceptible' animals: sensitivity to antidepressants.
Brian Platt, Janet Schulenberg, Nicole Klee, Maryam Nizami, Janet A Clark

Psychopharmacology (Berl)· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-(Pyrrolidin-1-yl)ethyl-3,4-dihydroisoquinolin-1(2H)-one derivatives as potent and selective histamine-3 receptor antagonists.
Dahui Zhou, Jonathan L Gross, Adedayo B Adedoyin, Suzan B Aschmies, Julie Brennan, Brian J Platt

J Med Chem· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrrolidin-3-yl-N-methylbenzamides as potent histamine 3 receptor antagonists.
Dahui Zhou, Jonathan L Gross, Jean Y Sze, Adedayo B Adedoyin, Mark Bowlby, Brian J Platt

Bioorg Med Chem Lett· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The metabotropic glutamate receptor 7 allosteric modulator AMN082: a monoaminergic agent in disguise?
Stacey J Sukoff Rizzo, Sarah K Leonard, Adam Gilbert, Paul Dollings, Deborah L Smith, Brian J Platt

J Pharmacol Exp Ther· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of BRL 44408: antidepressant- and analgesic-like activity through selective alpha2A-adrenoceptor antagonism.
Jason M Dwyer, Brian J Platt, Stacey J Sukoff Rizzo, Claudine M Pulicicchio, Caitlin Wantuch

Int J Neuropsychopharmacol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depression-like phenotype following chronic CB1 receptor antagonism.
Chad E Beyer, Jason M Dwyer, Michael J Piesla, Brian J Platt, Ru Shen

Neurobiol Dis· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation.
Chad E Beyer, Jason M Dwyer, Brian J Platt, Sarah Neal, Bin Luo

Psychopharmacology (Berl)· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes.
Michele P Kelly, Sheree F Logue, Julie Brennan, Jonathon P Day, Subha Lakkaraju, Brian J Platt

Proc Natl Acad Sci U S A· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The synthesis and biological evaluation of quinolyl-piperazinyl piperidines as potent serotonin 5-HT1A antagonists.
Wayne E Childers, Lisa M Havran, Magda Asselin, James J Bicksler, Dan C Chong, Brian Platt

J Med Chem· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzimidazole- and indole-substituted 1,3'-bipyrrolidine benzamides as histamine H3 receptor antagonists.
Derek C Cole, Jonathan L Gross, Thomas A Comery, Suzan Aschmies, Warren D Hirst, Brian J Platt

Bioorg Med Chem Lett· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist.
Robert H Ring, Lee E Schechter, Sarah K Leonard, Jason M Dwyer, Brian J Platt

Neuropharmacology· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonists.
Ronald C Bernotas, Steven Lenicek, Schuyler Antane, Derek C Cole, Boyd L Harrison, Brian Platt

Bioorg Med Chem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.
Paige E Mahaney, Lori K Gavrin, Eugene J Trybulski, Gary P Stack, T An Vu, Brian Platt

J Med Chem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent.
Zoë A Hughes, Feng Liu, Brian J Platt, Jason M Dwyer, Claudine M Pulicicchio

Neuropharmacology· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466.
Lee E Schechter, Qian Lin, Deborah L Smith, Guoming Zhang, Qin Shan, Brian Platt

Neuropsychopharmacology· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.
Sarah K Leonard, Jason M Dwyer, Stacey J Sukoff Rizzo, Brian Platt, Sheree F Logue

Psychopharmacology (Berl)· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxine.
Zia Rahman, Robert H Ring, Kimberly Young, Brian Platt, Qian Lin

Brain Res· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Schedule-induced polydipsia: a rat model of obsessive-compulsive disorder.
Brian Platt, Chad E Beyer, Lee E Schechter, Sharon Rosenzweig-Lipson

Curr Protoc Neurosci· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing the levels of insulin-like growth factor-I by an IGF binding protein inhibitor produces anxiolytic and antidepressant-like effects.
Jessica E Malberg, Brian Platt, Stacey J Sukoff Rizzo, Robert H Ring, Irwin Lucki

Neuropsychopharmacology· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.
S Johannes R Rajarao, Brian Platt, Stacey J Sukoff, Qian Lin, Corey N Bender

Neuropeptides· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis